ArticleResearch and practice in thrombosis and haemostasis2024

Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial.

Riccardo M Fumagalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.